Cryosite Limited (ASX:CTE)
1.050
0.00 (0.00%)
Apr 21, 2026, 3:37 PM AEST
Cryosite Market Cap
Cryosite has a market cap or net worth of 51.25 million as of April 28, 2026. Its market cap has increased by 75.00% in one year.
Market Cap
51.25M
Enterprise Value
57.53M
Revenue
15.75M
Ranking
n/a
PE Ratio
24.46
Stock Price
1.05
Market Cap Chart
Since May 9, 2002, Cryosite's market cap has increased from 18.00 to 51.25M, an increase of 284,722,350.00%. That is a compound annual growth rate of 85.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 51.25M | 5.00% |
| Dec 29, 2025 | 48.81M | 17.65% |
| Dec 27, 2024 | 41.49M | 40.50% |
| Dec 29, 2023 | 29.53M | -17.12% |
| Dec 30, 2022 | 35.63M | 56.99% |
| Dec 31, 2021 | 22.70M | 22.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 830.65M |
| Healius | 388.48M |
| Australian Clinical Labs | 362.15M |
| Monash IVF Group | 284.43M |
| Rhythm Biosciences | 58.39M |
| INOVIQ | 45.05M |
| Microba Life Sciences | 44.15M |
| Genetic Signatures | 35.21M |